These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 37525217)

  • 1. Macrophage's role in solid tumors: two edges of a sword.
    Jahandideh A; Yarizadeh M; Noei-Khesht Masjedi M; Fatehnejad M; Jahandideh R; Soheili R; Eslami Y; Zokaei M; Ahmadvand A; Ghalamkarpour N; Kumar Pandey R; Nabi Afjadi M; Payandeh Z
    Cancer Cell Int; 2023 Jul; 23(1):150. PubMed ID: 37525217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophages as tools and targets in cancer therapy.
    Mantovani A; Allavena P; Marchesi F; Garlanda C
    Nat Rev Drug Discov; 2022 Nov; 21(11):799-820. PubMed ID: 35974096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in tumor microenvironment-targeted nanomedicine delivery approaches to overcome limitations of immune checkpoint blockade-based immunotherapy.
    Kim J; Hong J; Lee J; Fakhraei Lahiji S; Kim YH
    J Control Release; 2021 Apr; 332():109-126. PubMed ID: 33571549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of tumor-associated macrophage in breast cancer biology.
    Choi J; Gyamfi J; Jang H; Koo JS
    Histol Histopathol; 2018 Feb; 33(2):133-145. PubMed ID: 28681373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CAR-macrophage: A new immunotherapy candidate against solid tumors.
    Chen Y; Yu Z; Tan X; Jiang H; Xu Z; Fang Y; Han D; Hong W; Wei W; Tu J
    Biomed Pharmacother; 2021 Jul; 139():111605. PubMed ID: 33901872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
    Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
    Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
    [No Abstract]   [Full Text] [Related]  

  • 7. Macrophages in immunoregulation and therapeutics.
    Chen S; Saeed AFUH; Liu Q; Jiang Q; Xu H; Xiao GG; Rao L; Duo Y
    Signal Transduct Target Ther; 2023 May; 8(1):207. PubMed ID: 37211559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-associated macrophages in multiple myeloma: advances in biology and therapy.
    Sun J; Park C; Guenthner N; Gurley S; Zhang L; Lubben B; Adebayo O; Bash H; Chen Y; Maksimos M; Muz B; Azab AK
    J Immunother Cancer; 2022 Apr; 10(4):. PubMed ID: 35428704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetically engineered macrophages persist in solid tumors and locally deliver therapeutic proteins to activate immune responses.
    Brempelis KJ; Cowan CM; Kreuser SA; Labadie KP; Prieskorn BM; Lieberman NAP; Ene CI; Moyes KW; Chinn H; DeGolier KR; Matsumoto LR; Daniel SK; Yokoyama JK; Davis AD; Hoglund VJ; Smythe KS; Balcaitis SD; Jensen MC; Ellenbogen RG; Campbell JS; Pierce RH; Holland EC; Pillarisetty VG; Crane CA
    J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33115946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated bioinformatics analysis and experimental validation reveal ISG20 as a novel prognostic indicator expressed on M2 macrophage in glioma.
    Peng Y; Liu H; Wu Q; Wang L; Yu Y; Yin F; Feng C; Ren X; Liu T; Chen L; Zhu H
    BMC Cancer; 2023 Jun; 23(1):596. PubMed ID: 37380984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adoptive cellular immunotherapy for solid neoplasms beyond CAR-T.
    Liu Q; Li J; Zheng H; Yang S; Hua Y; Huang N; Kleeff J; Liao Q; Wu W
    Mol Cancer; 2023 Feb; 22(1):28. PubMed ID: 36750830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infiltration of CD163-positive macrophages in glioma tissues after treatment with anti-PD-L1 antibody and role of PI3Kγ inhibitor as a combination therapy with anti-PD-L1 antibody in in vivo model using temozolomide-resistant murine glioma-initiating cells.
    Miyazaki T; Ishikawa E; Matsuda M; Sugii N; Kohzuki H; Akutsu H; Sakamoto N; Takano S; Matsumura A
    Brain Tumor Pathol; 2020 Apr; 37(2):41-49. PubMed ID: 31980975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The implications of clinical risk factors, CAR index, and compositional changes of immune cells on hyperprogressive disease in non-small cell lung cancer patients receiving immunotherapy.
    Kim SR; Chun SH; Kim JR; Kim SY; Seo JY; Jung CK; Gil BM; Kim JO; Ko YH; Woo IS; Shim BY; Hong SH; Kang JH
    BMC Cancer; 2021 Jan; 21(1):19. PubMed ID: 33402127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophages and Extracellular Matrix in Breast Cancer: Partners in Crime or Protective Allies?
    Deligne C; Midwood KS
    Front Oncol; 2021; 11():620773. PubMed ID: 33718177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment and Validation of a Genetic Label Associated With M2 Macrophage Infiltration to Predict Survival in Patients With Colon Cancer and to Assist in Immunotherapy.
    Xu B; Peng Z; Yan G; Wang N; Chen M; Yao X; Sun M; An Y
    Front Genet; 2021; 12():726387. PubMed ID: 34552622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting human leukocyte antigen G with chimeric antigen receptors of natural killer cells convert immunosuppression to ablate solid tumors.
    Jan CI; Huang SW; Canoll P; Bruce JN; Lin YC; Pan CM; Lu HM; Chiu SC; Cho DY
    J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34663641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting tumor-associated macrophages: A potential treatment for solid tumors.
    Chen Y; Jin H; Song Y; Huang T; Cao J; Tang Q; Zou Z
    J Cell Physiol; 2021 May; 236(5):3445-3465. PubMed ID: 33200401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophages in melanoma: A double‑edged sword and targeted therapy strategies (Review).
    Zhou Q; Fang T; Wei S; Chai S; Yang H; Tao M; Cao Y
    Exp Ther Med; 2022 Oct; 24(4):640. PubMed ID: 36160877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stromal depletion by TALEN-edited universal hypoimmunogenic FAP-CAR T cells enables infiltration and anti-tumor cytotoxicity of tumor antigen-targeted CAR-T immunotherapy.
    Das S; Valton J; Duchateau P; Poirot L
    Front Immunol; 2023; 14():1172681. PubMed ID: 37251405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triptolide decreases tumor-associated macrophages infiltration and M2 polarization to remodel colon cancer immune microenvironment via inhibiting tumor-derived CXCL12.
    Jiang X; Cao G; Gao G; Wang W; Zhao J; Gao C
    J Cell Physiol; 2021 Jan; 236(1):193-204. PubMed ID: 32495392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.